NVO - EU drug regulators to assess potential impact of Catalent-Novo merger
2024-02-07 17:43:49 ET
More on Catalent
- Catalent - Novo Holdings Merger: Attractive Spread
- Catalent: Debt Remains An Overhang
- Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript
- Catalent ticks lower amid report Indiana plant may have quality issues
- Lilly reportedly worried about impact of Catalent/Novo deal